ALK-Abelló A/S (OTCMKTS:AKBLF – Get Free Report) shares were up 8.3% during mid-day trading on Wednesday. The stock traded as high as $36.50 and last traded at $36.50. Approximately 1,197 shares changed hands during mid-day trading, an increase of 127% from the average session volume of 528 shares. The stock had previously closed at $33.70.
ALK-Abelló A/S Stock Performance
The stock has a 50-day moving average price of $34.46 and a 200 day moving average price of $36.24.
About ALK-Abelló A/S
ALK-Abelló A/S is a Denmark-based pharmaceutical company focused on the research, development, manufacturing and commercialization of allergy immunotherapy products. The company’s treatments are designed to address the underlying causes of allergies by gradually increasing a patient’s tolerance to specific allergens, rather than treating symptoms alone.
Its portfolio includes sublingual allergy immunotherapy tablets and other products for conditions such as grass pollen, tree pollen, ragweed pollen and house dust mite allergies.
Further Reading
- Five stocks we like better than ALK-Abelló A/S
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for ALK-Abelló A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALK-Abelló A/S and related companies with MarketBeat.com's FREE daily email newsletter.
